share_log

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

HC Wainwright & Co.重申买入格林威治生命科学,维持36美元的目标股价
Benzinga ·  02/28 13:23

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price target.

HC Wainwright & Co. 分析师陈毅重申格林威治生命科学(纳斯达克股票代码:GLSI)的买入并维持36美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发